NeuroRx said the drug – RLF-100, sold under the brand-name Aviptadil – will be evaluated in phase 2 and 3 clinical trials at major medical centers at the University of Miami, Houston Methodist Hospital, the University of California-Irvine, NYU Langone Medical Center and Rambam Healthcare Campus in Haifa, Israel.
Is there another coronavirus treatment? What to know about the fast-tracked drug Aviptadil
International Business Times, June 24, 2020
June 24, 2020